MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.

Volume 7 (2010), Issue 8 (August)

1. Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia.
   Eur Heart J, 31(15): 1890-7. [Abstract] [Full-text]
2. Surgical site infections in a tertiary health care center: prospective cohort study.
   Surg Today, 40(8): 763-71. [Abstract] [Full-text]
3. A new approach for the discovery of antibiotics by targeting non-multiplying bacteria: a novel topical antibiotic for staphylococcal infections.
   PLoS One, 5(7): e11818. [Abstract] [Full-text]
4. Etiology of septic arthritis in children: an update for the new millennium.
   Am J Emerg Med. [Abstract] [Full-text]
5. Outcomes and management costs in patients hospitalized for skin and skin-structure infections.
   Am J Infect Control. [Abstract] [Full-text]
6. Epidemiology of methicillin-susceptible Staphylococcus aureus lineages in five major African towns: high prevalence of Panton-Valentine leukocidin genes.
   Clin Microbiol Infect. [Abstract] [Full-text]
7. Lack of evidence for persistent nasal colonization with community-acquired MRSA in a Central European Cohort.
   Clin Microbiol Infect. [Abstract] [Full-text]
8. Molecular characterisation of methicillin-resistant Staphylococcus aureus (MRSA) from keratitis patients: a microbiological analysis.
   Br J Ophthalmol, 94(8): 994-8. [Abstract] [Full-text]
9. IFN-gamma enhances killing of methicillin-resistant Staphylococcus aureus by human monocytes more effectively than GM-CSF in the presence of daptomycin and other antibiotics.
   Cytokine, 51(3): 274-7. [Abstract] [Full-text]
10. Community-acquired methicillin-resistant Staphylococcus aureus pericarditis presenting as cardiac tamponade.
    South Med J, 103(8): 834-6. [Abstract] [Full-text]
11. Unsuspected polymicrobial brain abscess arising from an intra-abdominal source in a patient with hereditary hemorrhagic telangiectasia.
    South Med J, 103(8): 842-4. [Abstract] [Full-text]
12. The need for continued monitoring of antibiotic resistance patterns in clinical isolates of Staphylococcus aureus from London and Malta.
    Ann Clin Microbiol Antimicrob, 9: 20. [Abstract] [Full-text]
13. Emergency Open Surgical Treatment of Extravasations of Cytostatic Agents in the Upper Extremity.
    Handchir Mikrochir Plast Chir, 42(4): 247-250. [Abstract] [Full-text]
14. Methicillin-resistant Staphylococcus aureus (MRSA) ST398 associated with clinical and subclinical mastitis in Belgian cows.
    Vet Microbiol, 144(1): 166-71. [Abstract] [Full-text]
15. Community-acquired methicillin-resistant Staphylococcus aureus: community transmission, pathogenesis, and drug resistance.
    J Infect Chemother, 16(4): 225-54. [Abstract] [Full-text]
16. Emergence of the community-acquired methicillin-resistant Staphylococcus aureus USA300 clone in a Japanese child, demonstrating multiple divergent strains in Japan.
    J Infect Chemother, 16(4): 292-7. [Abstract] [Full-text]
17. Prevalence of Staphylococcus aureus colonization in orthopaedic surgeons and their patients: a prospective cohort controlled study.
    J Bone Joint Surg Am, 92(9): 1815-9. [Abstract] [Full-text]
18. Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery.
    J Bone Joint Surg Am, 92(9): 1820-6. [Abstract] [Full-text]
19. Methicillin resistance transfer from Staphylocccus epidermidis to methicillin-susceptible Staphylococcus aureus in a patient during antibiotic therapy.
    PLoS One, 5(7): e11841. [Abstract] [Full-text]
20. Screening and decolonization: does methicillin-susceptible Staphylococcus aureus hold lessons for methicillin-resistant S. aureus?
    Clin Infect Dis, 51(5): 585-90. [Abstract] [Full-text]
21. Clinical correlates of Panton-Valentine leukocidin (PVL), PVL isoforms, and clonal complex in the Staphylococcus aureus population of Northern Australia.
    J Infect Dis, 202(5): 760-9. [Abstract] [Full-text]
22. Bioactive 1,4-dihydroxy-5-phenyl-2-pyridinone alkaloids from Septoria pistaciarum.
    J Nat Prod, 73(7): 1250-3. [Abstract] [Full-text]
23. Acute community-acquired osteoarticular infections in children: high incidence of concomitant bone and joint involvement.
    J Microbiol Immunol Infect, 43(4): 332-8. [Abstract] [Full-text]
24. Synthesis and antibacterial activity of 3-O-carbamoyl derivatives of 6,11-di-O-methylerythromycin A: a novel class of acylides.
    Eur J Med Chem, 45(9): 3636-44. [Abstract] [Full-text]
25. Synthesis and biological activities of novel amine-derived bis-azoles as potential antibacterial and antifungal agents.
    Eur J Med Chem, 45(9): 4388-98. [Abstract] [Full-text]
26. Structural characterization and antibacterial activity against clinical isolates of Staphylococcus of N-phenylamide of monensin A and its 1:1 complexes with monovalent cations.
    Eur J Med Chem, 45(9): 4050-7. [Abstract] [Full-text]
27. Synthesis, structure and in vitro antibacterial activities of new hybrid disinfectants quaternary ammonium compounds: pyridinium and quinolinium stilbene benzenesulfonates.
    Eur J Med Chem, 45(9): 4199-208. [Abstract] [Full-text]
28. Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones.
    J Cataract Refract Surg, 36(9): 1588-98. [Abstract] [Full-text]
29. Penetration of linezolid into rabbit intervertebral discs and surrounding tissues.
    Eur Spine J. [Abstract] [Full-text]
30. Antimicrobial-susceptible patterns of Staphylococcus aureus isolated from surgical infections: a new approach.
    J Infect Chemother. [Abstract] [Full-text]
31. Community-associated methicillin-resistant Staphylococcus aureus (MRSA): an overview for nurses.
    Nurs Womens Health, 14(4): 310-6; quiz 317. [Abstract] [Full-text]
32. Antistaphylococcal nanocomposite films based on enzyme-nanotube conjugates.
    ACS Nano, 4(7): 3993-4000. [Abstract] [Full-text]
33. Nanosized aluminum altered immune function.
    ACS Nano, 4(7): 3661-70. [Abstract] [Full-text]
34. Decal bone matrix as a local antibiotic delivery vehicle in a MRSA-infected bone model: An experimental study.
    Indian J Orthop, 44(3): 246-51. [Abstract] [Full-text]
35. A pre- and postoperative bacteriological study of chronic suppurative otitis media.
    Infection. [Abstract] [Full-text]
36. Health care-associated invasive MRSA infections, 2005-2008.
    JAMA, 304(6): 641-8. [Abstract] [Full-text]
37. Apples, Oranges, and Methicillin-Resistant Staphylococcus aureus.
    Dermatol Surg. [Abstract] [Full-text]
38. Newer antibacterial agents and their potential role in cystic fibrosis pulmonary exacerbation management.
    J Antimicrob Chemother, 65(9): 1853-61. [Abstract] [Full-text]
39. Staphylococcus aureus bacteriuria as a prognosticator for outcome of Staphylococcus aureus bacteremia: a case-control study.
    BMC Infect Dis, 10: 225. [Abstract] [Full-text]
40. Primary Staphylococcus aureus urinary tract infection: the role of undetected hematogenous seeding of the urinary tract.
    Eur J Clin Microbiol Infect Dis, 29(9): 1095-101. [Abstract] [Full-text]
41. Risk factors for major morbidity after hepatectomy for hepatocellular carcinoma in 293 recent cases.
    J Hepatobiliary Pancreat Sci, 17(5): 709-18. [Abstract] [Full-text]
42. Cluster randomised controlled trial of an infection control education and training intervention programme focusing on meticillin-resistant Staphylococcus aureus in nursing homes for older people.
    J Hosp Infect, 76(1): 36-41. [Abstract] [Full-text]
43. Effects of gastric acidity on peristomal infection after percutaneous endoscopic gastrostomy placement.
    J Hosp Infect, 76(1): 42-5. [Abstract] [Full-text]
44. Public health surveillance for methicillin-resistant Staphylococcus aureus: comparison of methods for classifying health care- and community-associated infections.
    Am J Public Health, 100(9): 1777-83. [Abstract] [Full-text]
45. In vitro and in vivo antibiofilm activity of a coral associated actinomycete against drug resistant Staphylococcus aureus biofilms.
    Biofouling, 26(6): 711-7. [Abstract] [Full-text]
46. The matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS)-based protein peaks of 4448 and 5302Da are not associated with the presence of Panton-Valentine leukocidin.
    Int J Med Microbiol. [Abstract] [Full-text]
47. Periorbital Necrotizing Fasciitis Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus Periorbital Necrotizing Fasciitis.
    Orbit. [Abstract] [Full-text]
48. First report of methicillin-resistant Staphylococcus aureus from cage-cultured tilapia (Oreochromis niloticus).
    Vet Microbiol, 144(3): 502-4. [Abstract] [Full-text]
49. Bacterial colonization of chronic leg ulcers: current results compared with data 5 years ago in a specialized dermatology department.
    J Eur Acad Dermatol Venereol, 24(9): 1017-25. [Abstract] [Full-text]
50. Cervical necrotizing fasciitis due to methicillin-resistant Staphylococcus aureus: a case report.
    Int J Oral Maxillofac Surg, 39(8): 830-4. [Abstract] [Full-text]
51. Healthcare-associated versus community-acquired infections: a new challenge for science and society.
    Int J Med Microbiol, 300(6): 342-5. [Abstract] [Full-text]
52. Purification and characterization of a novel delta-lysin variant that inhibits Staphylococcus aureus and has limited hemolytic activity.
    Peptides, 31(9): 1661-8. [Abstract] [Full-text]
53. Immunotherapeutic strategies to combat staphylococcal infections.
    Int J Med Microbiol, 300(6): 402-10. [Abstract] [Full-text]
54. Crystal structure of glyceraldehyde-3-phosphate dehydrogenase 1 from methicillin-resistant Staphylococcus aureus MRSA252 provides novel insights into substrate binding and catalytic mechanism.
    J Mol Biol, 401(5): 949-68. [Abstract] [Full-text]
55. New coated SPME fibers for extraction and fast HPLC determination of selected drugs in human blood.
    J Pharm Biomed Anal, 53(4): 1022-7. [Abstract] [Full-text]
56. Synthesis and in vitro antibacterial activity of novel fluoroquinolone derivatives containing substituted piperidines.
    Bioorg Med Chem Lett, 20(17): 5195-8. [Abstract] [Full-text]
57. Pediatric abscess characteristics associated with hospital admission from the ED.
    Am J Emerg Med. [Abstract] [Full-text]
58. Design, synthesis, and biological evaluation of a novel series of quercetin diacylglucosides as potent anti-MRSA and anti-VRE agents.
    Bioorg Med Chem Lett, 20(17): 5349-52. [Abstract] [Full-text]
59. New coated SPME fibers for extraction and fast HPLC determination of selected drugs in human blood.
    J Pharm Biomed Anal, 53(4): 1022-7. [Abstract] [Full-text]
60. New coated SPME fibers for extraction and fast HPLC determination of selected drugs in human blood.
    J Pharm Biomed Anal, 53(4): 1022-7. [Abstract] [Full-text]
61. Treatment of glenohumeral sepsis with a commercially produced antibiotic-impregnated cement spacer.
    J Shoulder Elbow Surg, 19(6): 868-73. [Abstract] [Full-text]
62. Time to blood culture positivity in Staphylococcus aureus bacteremia: association with 30-day mortality.
    J Infect, 61(3): 197-204. [Abstract] [Full-text]
63. Ciprofloxacin-modified electrosynthesized hydrogel coatings to prevent titanium-implant-associated infections.
    Acta Biomater. [Abstract] [Full-text]
64. Daptomycin as a possible new treatment option for surgical management of Methicillin-Resistant Staphylococcus aureus sternal wound infection after cardiac surgery.
    J Cardiothorac Surg, 5: 57. [Abstract] [Full-text]
65. The performance of the BD geneOhm MRSA assay for MRSA isolated from clinical patients in Japan, including the effects of specimen contamination and ways to improve it.
    J Infect Chemother. [Abstract] [Full-text]
66. An initial dosing method for teicoplanin based on the area under the serum concentration time curve required for MRSA eradication.
    J Infect Chemother. [Abstract] [Full-text]
67. Two cases of corneal ulcer due to methicillin-resistant Staphylococcus aureus in high risk groups.
    Korean J Ophthalmol, 24(4): 240-4. [Abstract] [Full-text]
68. Emerging drugs for complicated skin and skin-structure infections.
    Expert Opin Emerg Drugs, 15(3): 509-20. [Abstract] [Full-text]
69. Successful treatment for carriage of methicillin-resistant Staphylococcus aureus and importance of follow-up.
    Antimicrob Agents Chemother, 54(9): 4020-5. [Abstract] [Full-text]
70. Underestimation of vancomycin and teicoplanin MICs by broth microdilution leads to underdetection of glycopeptide-intermediate isolates of Staphylococcus aureus.
    Antimicrob Agents Chemother, 54(9): 3861-70. [Abstract] [Full-text]
71. Use of pristinamycin for infections by gram-positive bacteria: clinical experience at an Australian hospital.
    Antimicrob Agents Chemother, 54(9): 3949-52. [Abstract] [Full-text]
72. Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.
    Antimicrob Agents Chemother, 54(9): 3825-33. [Abstract] [Full-text]
73. Cloning and occurrence of czrC, a gene conferring cadmium and zinc resistance in methicillin-resistant Staphylococcus aureus CC398 isolates.
    Antimicrob Agents Chemother, 54(9): 3605-8. [Abstract] [Full-text]
74. Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States.
    Antimicrob Agents Chemother, 54(9): 3804-11. [Abstract] [Full-text]
75. Detection and quantification of methicillin-resistant Staphylococcus aureus (MRSA) clones in retail meat products.
    Lett Appl Microbiol, 51(3): 338-42. [Abstract] [Full-text]
76. Use of topical negative pressure in assisted abdominal closure does not lead to high incidence of enteric fistulae.
    Colorectal Dis, 12(9): 931-4. [Abstract] [Full-text]
77. Lack of increase in vancomycin resistance of pediatric methicillin-resistant Staphylococcus aureus Isolates from 2000 to 2007.
    Pediatr Infect Dis J, 29(9): 882-4. [Abstract] [Full-text]
78. Characterization of community and hospital Staphylococcus aureus isolates in Southampton, UK.
    J Med Microbiol, 59: 1084-8. [Abstract] [Full-text]
79. Nasal septal abscess and facial cellulitis caused by community-acquired methicillin-resistant Staphylococcus aureus.
    J Laryngol Otol, 124(9): 1014-6. [Abstract] [Full-text]
80. Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis.
    Crit Care Med, 38(9): 1802-8. [Abstract] [Full-text]
81. Increased vancomycin minimum inhibitory concentration among Staphylococcus aureus isolates in Malaysia.
    J Med Microbiol. [Abstract] [Full-text]
82. Antimicrobial susceptibility of Staphylococcus aureus in children with atopic dermatitis.
    Pediatr Int. [Abstract] [Full-text]
83. Necrotizing soft tissue infections in the intensive care unit.
    Crit Care Med, 38(9): S460-8. [Abstract] [Full-text]
84. Sinogenic orbital and subperiosteal abscesses: microbiology and methicillin-resistant Staphylococcus aureus incidence.
    Otolaryngol Head Neck Surg, 143(3): 392-6. [Abstract] [Full-text]
85. Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection.
    Ann Emerg Med, 56(3): 283-7. [Abstract] [Full-text]
86. Activity of telavancin and comparator antimicrobial agents tested against Staphylococcus spp. isolated from hospitalised patients in Europe (2007-2008).
    Int J Antimicrob Agents, 36(4): 374-9. [Abstract] [Full-text]
87. Characterization and structure identification of an antimicrobial peptide, hominicin, produced by Staphylococcus hominis MBBL 2-9.
    Biochem Biophys Res Commun, 399(2): 133-8. [Abstract] [Full-text]
88. Isolation of meticillin-resistant Staphylococcus aureus (MRSA) from swine in Japan.
    Int J Antimicrob Agents, 36(4): 352-4. [Abstract] [Full-text]
89. MALDI-TOF MS fingerprinting allows for discrimination of major methicillin-resistant Staphylococcus aureus lineages.
    Int J Med Microbiol. [Abstract] [Full-text]
90. Comparison of sampling methods used for MRSA-classification of herds with breeding pigs.
    Vet Microbiol. [Abstract] [Full-text]
91. Methicillin-resistant Staphylococcus aureus infection in combat support hospitals in three regions of Iraq.
    Epidemiol Infect. [Abstract] [Full-text]
92. Development of chitosan-collagen hydrogel incorporated with lysostaphin (CCHL) burn dressing with anti-methicillin-resistant Staphylococcus aureus and promotion wound healing properties.
    Drug Deliv. [Abstract] [Full-text]
93. A comparison of antibacterial activity against Methicillin-Resistant Staphylococcus aureus and gram-negative organisms for antimicrobial compounds in a unique composite wound dressing.
    Adv Skin Wound Care, 23(9): 406-13. [Abstract] [Full-text]
94. Progression to bacteremia in critical care patients colonized with methicillin-resistant Staphylococcus aureus expressing Panton-Valentine leukocidin.
    Diagn Microbiol Infect Dis, 68(1): 28-33. [Abstract] [Full-text]
95. In vitro activity of tigecycline in combination with gentamicin against biofilm-forming Staphylococcus aureus.
    Diagn Microbiol Infect Dis, 68(1): 1-6. [Abstract] [Full-text]
96. Generation of ramoplanin-resistant Staphylococcus aureus.
    FEMS Microbiol Lett, 310(2): 104-11. [Abstract] [Full-text]
97. Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection.
    Clin Infect Dis, 51(6): 641-50. [Abstract] [Full-text]
98. Serious infections caused by methicillin-resistant Staphylococcus aureus.
    Clin Infect Dis, 51: S183-97. [Abstract] [Full-text]
99. Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus.
    Clin Infect Dis, 51: S176-82. [Abstract] [Full-text]
100. The outcomes of methicillin-resistant Staphylococcus aureus infection after living donor liver transplantation in a Japanese center.
     J Hepatobiliary Pancreat Sci, 17(6): 839-43. [Abstract] [Full-text]
101. In vitro additive effect of Hyptis martiusii in the resistance to aminoglycosides of methicillin-resistant Staphylococcus aureus.
     Pharm Biol, 48(9): 1002-6. [Abstract] [Full-text]
102. Are short training sessions on hand hygiene effective in preventing hospital-acquired MRSA? A time-series analysis.
     Am J Infect Control, 38(7): 559-61. [Abstract] [Full-text]
103. Increased use of alcohol-based hand sanitizers and successful eradication of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit: a multivariate time series analysis.
     Am J Infect Control, 38(7): 529-34. [Abstract] [Full-text]
104. Laser light combined with a photosensitizer may eliminate methicillin-resistant strains of Staphylococcus aureus.
     Lasers Med Sci, 25(5): 743-8. [Abstract] [Full-text]
105. Emergence of vancomycin-intermediate Staphylococcus aureus from predominant methicillin-resistant S. aureus clones in a Korean hospital.
     J Microbiol, 48(4): 533-5. [Abstract] [Full-text]
106. Clinical evaluation of Bio-Rad MRSASelect medium for the detection of livestock-associated methicillin-resistant Staphylococcus aureus.
     Eur J Clin Microbiol Infect Dis. [Abstract] [Full-text]
107. Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation.
     Am J Respir Crit Care Med, 182(5): 627-32. [Abstract] [Full-text]
108. Multistep virtual screening for rapid and efficient identification of non-nucleoside bacterial thymidine kinase inhibitors.
     Chemistry, 16(31): 9630-7. [Abstract] [Full-text]
109. Community-acquired Staphylococcus aureus pneumonia among hospitalized children in Hawaii.
     Pediatr Pulmonol, 45(9): 898-905. [Abstract] [Full-text]
110. Mobile genetic elements of Staphylococcus aureus.
     Cell Mol Life Sci, 67(18): 3057-71. [Abstract] [Full-text]
111. Daptomycin, a bacterial lipopeptide synthesized by a nonribosomal machinery.
     J Biol Chem, 285(36): 27501-8. [Abstract] [Full-text]
112. Ward assessment of SmartIdeas Project: bringing source isolation to the patient.
     J Hosp Infect, 76(2): 103-7. [Abstract] [Full-text]
113. Epidemiology meets econometrics: using time-series analysis to observe the impact of bed occupancy rates on the spread of multidrug-resistant bacteria.
     J Hosp Infect, 76(2): 108-13. [Abstract] [Full-text]
114. Clinical and economic outcomes for patients with health care-associated Staphylococcus aureus pneumonia.
     J Clin Microbiol, 48(9): 3258-62. [Abstract] [Full-text]
115. Secular trends of healthcare-associated infections at a teaching hospital in Taiwan, 1981-2007.
     J Hosp Infect, 76(2): 143-9. [Abstract] [Full-text]
116. Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model.
     J Infect Dis, 202(7): 1050-8. [Abstract] [Full-text]
117. Dimers of nostocarboline with potent antibacterial activity.
     Chemotherapy, 56(4): 318-24. [Abstract] [Full-text]
118. Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice.
     J Exp Med, 207(9): 1863-70. [Abstract] [Full-text]
119. Functional analysis, overexpression, and kinetic characterization of pyruvate kinase from methicillin-resistant Staphylococcus aureus.
     Biochemistry, 49(35): 7733-47. [Abstract] [Full-text]

© 2004-2012 MRSA Research Today. All Rights Reserved.